Lilly Opens Phase 3 Clinical Trial for Selpercatinib (LOXO-292) in RET-Mutant Medullary Thyroid CancerFukushima Nuclear Disaster | Increased Thyroid Cancer in U.S. The gene discussed is RET; the disease is thyroid gland disorder.